Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
A retrospective study comparing different injection approaches of 5-aminolevulinic acid in patients with non-melanoma skin cancer
By
- AMS
posted
Oct 16, 2020 06:49 AM
0
Recommend
.
0 comments
0 views
Related Content
SkinCeuticals, CeraVe, La Roche-Posay & Melanoma Research Alliance Launch Three-Year Partnership in the United States
- AMS
Added May 04, 2020
Blog Entry
1
- AMS
Added Aug 11, 2021
Blog Entry
Cosmetic injections to relax wrinkles and add volume
- AMS
Added Oct 20, 2022
Blog Entry
Injectable Dermal Fillers Don't Just Fill – They Also Lift, New Study Suggests
- AMS
Added May 11, 2021
Blog Entry
Galderma Receives FDA Approval for Restylane® Contour for Cheek Augmentation and Correction of Midface Contour Deficiencies
- AMS
Added Jul 13, 2021
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic